Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Clinical trial NCT00738062 · COMPLETED

Trial details

NCT number: NCT00738062
Sponsor: Chelsea Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neurogenic Orthostatic Hypotension Non-Diabetic Autonomic Neuropathy Multiple System Atrophy Dopamine Beta Hydroxylase Deficiency

Start date: 2008-01-01
Primary completion: 2010-12-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.